Cross-institution positioning
Mar 27, 2026Strong institutional reduction. 3 reducing across 3 comparable institutions.
Source: Schedule 13 researchTIMKEN CO
Latest stored close $116.12 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 3 reducing across 3 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +7.5% YoY; Net income -63.2% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 61% through its reported 52-week range; +50.6% over one year.
Source: Stored historical price seriesFiled Mar 27, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | BOLDEA LUCIAN | FTax/price withholding or payment | Common Stock | 3.3K | $119.78 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | BOLDEA LUCIAN | AGrant, award, or other acquisition | Common Stock | 7.9K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | BOLDEA LUCIAN | FTax/price withholding or payment | Common Stock | 12.8K | $119.78 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | BOLDEA LUCIAN | AGrant, award, or other acquisition | Common Stock | 30.3K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Ribaudo Stephen Philip | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 8.9K | $0.00 | Direct | Sep 1, 2026 |
| Sep 1, 2026 | Ribaudo Stephen Philip | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 6.0K | $0.00 | Direct | Sep 1, 2026 |
| Sep 1, 2026 | Ribaudo Stephen Philip | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 8.3K | $0.00 | Direct | Sep 1, 2026 |
| Aug 10, 2026 | Kyle Richard G | SOpen-market or private sale | Common Stock | 13.6K | $126.63 | Direct | Aug 11, 2026 |
| Jun 5, 2026 | Rajendra Ajita G | SOpen-market or private sale | Common Stock | 8.5K | $131.34 | Direct | Jun 9, 2026 |
| May 27, 2026 | Kyle Richard G | SOpen-market or private sale | Common Stock | 8.4K | $127.35 | Direct | May 29, 2026 |
| May 18, 2026 | Kyle Richard G | GGift | Common Stock | 646 | $0.00 | Direct | May 18, 2026 |
| May 8, 2026 | Crowe Maria A | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 1.3K | $0.00 | Direct | May 12, 2026 |
| May 8, 2026 | Harrell Elizabeth Ann | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 1.3K | $0.00 | Direct | May 12, 2026 |
| May 8, 2026 | Lauber Sarah C | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 1.3K | $0.00 | Direct | May 12, 2026 |
| May 8, 2026 | Kyle Richard G | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 1.3K | $0.00 | Direct | May 12, 2026 |
| May 8, 2026 | Kyle Richard G | SOpen-market or private sale | Common Stock | 37.2K | $117.34 | Direct | May 12, 2026 |
| May 8, 2026 | SULLIVAN FRANK C | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 1.3K | $0.00 | Direct | May 12, 2026 |
| May 8, 2026 | TIMKEN WARD J JR | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 1.3K | $0.00 | Direct | May 12, 2026 |
| May 8, 2026 | TIMKEN JOHN M JR | AGrant, award, or other acquisition · derivative | Restricted Share Unit | 1.3K | $0.00 | Direct | May 12, 2026 |
| May 8, 2026 | TIMKEN JOHN M JR | SOpen-market or private sale | Common Stock | 15.0K | $116.51 | Direct | May 12, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 4, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 31, 2026 | 8-K | 5.02, 8.01 | Director or executive change; Other event | — | Filing |
| Jul 6, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| May 8, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| May 6, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 21, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Feb 17, 2026 | 8-K | 8.01 | Other event | — | Filing |
| Feb 13, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Feb 4, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Oct 29, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $1.3B | +7.5% |
| Ended Mar 31, 2026 | $1.2B | +8.0% |
| Ended Sep 30, 2025 | $1.2B | +2.7% |
| Ended Jun 30, 2025 | $1.2B | -0.8% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $4.6B | +0.2% |
| Ended Dec 31, 2024 | $4.6B | -4.1% |
| Ended Dec 31, 2023 | $4.8B | +6.1% |
| Ended Dec 31, 2022 | $4.5B | +8.8% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Reported reduction | 11 -6.2M | 12.00% +3.26 pts | $97.54 | $97.56 | $116.12 |
| Fidelity / FMR CIK0000315066 | Dec 31, 2025 observed Feb 5, 2026 filed · 36d Schedule 13G amendment | Reported reduction | 2.8K -757 | 12.00% +6.90 pts | $84.13 | $102.15 | $116.12 |
| Fidelity / FMR CIK0000315066 | Jun 30, 2025 observed Aug 6, 2025 filed · 37d Schedule 13G amendment | Reported reduction | 3.5K -4.8M | 5.10% -1.77 pts | $72.55 | $73.57 | $116.12 |
Compare TKR with other securities showing similar institutional activity or recent accumulation across several tracked institutions.